ÃâÒßѧÊÔÌâ
+vCW${U Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
$,B@yiie 1. Fas(CD95)/FasL
"e~"-B7(\Y 2. common chain of cytokine receptor
zmh3
Q
a( 3 . TCR/CD3 complex
}u8 D5Q<( 4. negaive selection of thymocytes
^DS+O> 5. artificial active immune
}mSfg 6. anti-idiotypic
9% AL f 9 7. IgSF
rWMG_eP: 8. Integrin
bol#[_~ 9. chemokine
j{u!/FD 10. B7/CD28
f ")*I ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
#v`J]I)$ 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
eb>YvC 2. ±È½ÏCTLºÍNKɱÉË°Ðϸ°ûʱʶ±ðºÍɱÉË»úÖƵÄÌص㡣
ghd*EXrF
H 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆʵÑé·½°¸¿Ë¡´Ë»ùÒò¡£
P
2;I0 ! 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
K@zzseQ}= )R`w{V 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
s`:-6{E µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
(C
EXPf Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
;/8oP ;X2 1. B7/CD28
}{Ncww!iN 2. Th1 subset
)m Uc
!TP 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
l[q%1-N 4. antibody affinity maturation
-Vi"hSsUP 5. AP-1
&[hq !v 6. single chain variable fragment£¨ScFv£©
V_g9oR_ 7. NK cell receptor
zp2IpYQ,3 8. Zinkernagel-Doherty phenomenon
)TBG-<wt 9. Ig fold
Ex
?)FL$4 10. CD40/CD40L
1cyX9X ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
D+.h*{gD 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØϵ¡£
:>.~"uWo{ 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
EQkv&k
5X 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹Øϵ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
pO
n>m1| Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
9@-^!DBM 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁÜ°Íϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
r2T-= XWB 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
}7Si2S 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æרҵ£©¡£
rZDlPp>BPZ Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
F(8>"(C £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
r`|/qP:T[ Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
VN[h0+n4Th 1.Co-stimulators (or co-stimulating molecules)
X$zlR)Re 2.NK-kB
bGvALz' 3.Immunoglobulin superfamily
J 3fcnI 4.antigen-presenting cell (APC)
xS` %3+| 5.death domain
vMXS%Q 6.CCR and CXCR
<a |$Bl 7.Lectin (or mitogen)
SLL%XF~/Sb 8.Clusters of differentiation, CD)
]k%Yz@*S 9.B7 family
M* (]hu0! 10.Cytotoxic T lymphocyte, CTL)
m<wng2`NTv 11.IL-15 and IL-15 receptor (IL-15R)
yAoJ?<4^W 12.MHC restriction
0(;d<u)fS 13.Affinity-chromatography
k~u$&a 14.Cyctosprin A, CsA
maLKUSgo 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
T^8t<S@` ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
15_OtK 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
;}{%|UAsx 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£
vBUx)l 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣
P=eVp(/x Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
zCT Wi ÃâÒßѧרҵ£º
!Ac <A. 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
Qj?+R F6( Ïû»¯ÄÚ¿Æ£º
j0!Z 20 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
q4<3 O"c1 ѪҺ²¡Ñ§×¨Òµ£º
.oYUA} 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
]'=]=o~4 Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
9D:p~_"g (רҵ»ù´¡: ÃâÒßѧ)
z iR} Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
W~+
] 7< 1. ADCC(antibody dependent cell-mediated cytotoxicity)
{wRs V=* 2. »·æß¾úËØ(cyclosporin)
yazC2Enes8 3. KIR(killer cell inhibitory receptor)
`3^*K/K\ 4. HLDA(human leucocyte differentiation antigen)
mOr>*uR 5. Interleukin 18(IL-18)
"qUUH4mR` 6. ÕûºÏËØ(integrin)
6Yebc_, R 7. Fas/FasL
`me2Q 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
Ub*Gv(Pg 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
>4`("# 10. Th1/Th2
uyMxBc%6 11. »ùÒòÒßÃç(DNAÒßÃç)
2`I"
QU 12. chemokines and chemokine receptor
6U6,Wu 13. ÃâÒßÄÍÊÜ
ZIQy}b' 14. ¹²´Ì¼¤·Ö×Ó
bB@1tp0+ 15. ËÀÍö½á¹¹Óò(death domain)
ya3A^&: ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
7J,j 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉË°Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
JsI`# 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»Æƶø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
R!b<Sg £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
St9W{ £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
yEyx.Mh.Af £¨3£©1984Ä꣺ÁÜ°Íϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
[ZU6z?Pf £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
Z
.VIb| 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄЩÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
G#-t&gO3 Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
G vMhgG=D ÎÊ´ðÌâ(ÿÌâ25·Ö)
S[(Tpk2_ 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
F8mS5oB|^
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
$q,2VH :Ip 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆһϵͳʵÑé,¼ÓÒÔ֤ʵ¡£
m/uBM6SXx 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃÇ°¾°¡£